Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders : current practice in Europe 2009
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1192866
Author(s) Ljungman, P; Bregni, M; Brune, M; Cornelissen, J; de Witte, T; Dini, G; Einsele, H; Gaspar, H B; Gratwohl, A; Passweg, J; Peters, C; Rocha, V; Saccardi, R; Schouten, H; Sureda, A; Tichelli, A; Velardi, A; Niederwieser, D; European Group for Blood and Marrow Transplantation
Author(s) at UniBasel Gratwohl, Alois A.
Passweg, Jakob R.
Tichelli, André
Year 2010
Title Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders : current practice in Europe 2009
Journal Bone marrow transplantation
Volume 45
Number 2
Pages / Article-Number 219-34
Keywords haematopoietic SCT, indications, recommendations, Europe
Abstract The European Group for Blood and Marrow Transplantation regularly publishes special reports on the current practice of haematopoietic SCT for haematological diseases, solid tumours and immune disorders in Europe. Major changes have occurred since the first report was published. HSCT today includes grafting with allogeneic and autologous stem cells derived from BM, peripheral blood and cord blood. With reduced-intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged, such as autoimmune disorders and AL amyloidosis for autologous HSCT and solid tumours, myeloproliferative syndromes and specific subgroups of lymphomas for allogeneic transplants. The introduction of alternative therapies, such as imatinib for CML, has challenged well-established indications. An updated report with revised tables and operating definitions is presented.
Publisher Nature Publishing Group
ISSN/ISBN 0268-3369
edoc-URL http://edoc.unibas.ch/dok/A6003114
Full Text on edoc No
Digital Object Identifier DOI 10.1038/bmt.2009.141
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19584824
ISI-Number WOS:000274397400002
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.629 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
08/08/2020